GlassScriptPhysician profile
Tyler Adams
NPI 1568904563
$1,651.40
in general payments reported to CMS, 2019-2025
18 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $436 · 2023: $403 · 2024: $497 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $212.56 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $202.74 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $181.09 | 2022-2025 | Ubrelvy, Vraylar, Synthroid |
| Bayer Healthcare Pharmaceuticals INC. | $157.27 | 2022-2024 | |
| Novo Nordisk INC | $137.49 | 2022-2025 | Rybelsus, Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $136.35 | 2021-2024 | Breztri, Farxiga |
| Astellas Pharma US INC | $99.18 | 2021-2024 | Veozah |
| Amarin Pharma, INC. | $97.92 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $90.66 | 2023-2024 | Gemtesa |
| Exact Sciences Corporation | $47.24 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $43.52 | 2023-2024 | Repatha, Otezla |
| Sunovion Pharmaceuticals INC. | $42.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.32 | 2021-2022 | |
| Pfizer INC. | $41.83 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $38.86 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $37.55 | 2024 | Odactra, Ragwitek, Grastek |
| Biohaven Pharmaceutical Holding Company LTD. | $24.98 | 2022 | |
| Eisai INC. | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.